Clinical Presentations and Predictors of In-Hospital Mortality in Illicit Drug Users in the New Psychoactive Substances (NPS) Endemic Era in Taiwan. [PDF]
Toxics, 2022 Yeh HT +9 more
europepmc +1 more source
A systematic review of the effects of novel psychoactive substances “legal highs” on people with severe mental illness [PDF]
, 2016 Introduction: Novel psychoactive substances (NPS) are synthetic substances that have been developed to produce altered states of consciousness and perceptions.
Anderson +30 more
core +1 more source
Establishment of Neurotoxicity Assessment Using Microelectrode Array (MEA) with hiPSC-Derived Neurons and Evaluation of New Psychoactive Substances (NPS). [PDF]
Int J Stem Cells, 2022 Kang KR +12 more
europepmc +1 more source
Combined NMDA Inhibitor Use in a Patient With Multisubstance-induced Psychotic Disorder [PDF]
, 2018 This document is an Accepted Manuscript reprinted from Journal of Addiction Medicine, Vol. 12 (3): 247-251, May 2018, with permission of Kluwer Law International. Under embargo until 1 May 2019.
Calabrò, Giuseppa +9 more
core +2 more sources
Hair analysis for New Psychoactive Substances (NPS): Still far from becoming the tool to study NPS spread in the community? [PDF]
Toxicol Rep, 2021 Florou D, Boumba VA.
europepmc +1 more source
Re-emergence of HIV related to injecting drug use despite a comprehensive harm reduction environment:a cross sectional analysis [PDF]
, 2019 Background: In 2015, an outbreak of HIV was identified among people who inject drugs (PWID) in the Greater Glasgow and Clyde (GGC) area of Scotland, an area which distributes more than 1 million needles and syringes per year.
Ahmad +24 more
core +4 more sources
Towards Strengthened Preparedness and Response to New Psychoactive Substances in Europe
Emerging Trends in Drugs, Addictions, and HealthIn January 2022, the European Commission proposed to strengthen the mandate of the EMCDDA, transforming it into the new EU Drugs Agency (EUDA) [1]. This new regulation aims to improve data sharing, preparedness, surveillance, risk assessment, early ...
A. Gallegos
doaj +1 more source
Behavioral Pharmacology of New Psychoactive Substance (NPS): Cannabinoids
The rapid emergence of New Psychoactive substance (NPS) represents a significant challenge for public health, law enforcement, and regulatory bodies worldwide. New Psychoactive Substance (NPS) are synthetic substance designed to mimic the effects of traditional illicit drugs, such as cocaine, cannabis, stimulants, or ecstasy.
Snehal Namdeo, Chandrika Ahirwal
openaire +2 more sources
Клиническая и специальная психологияContext and relevance. Diagnosis of endogenous and exogenous psychosis can be difficult, especially when the production symptoms occur. As a theoretical basis for the study was used modern neurocognitive concept regarding mental disorders in ...
I.A. Alekseev, A.D. Shustov
doaj +1 more source
New Psychoactive Substances (NPS): Are We in Times of A Crisis or Between Crises?
International Journal of Emergency Mental Health and Human Resilience, 2016 Mankind has been experimenting with substances since time immemorial. Betel nuts from Timor, ancient Inca coca leaves, the Pharaohs “brewed alcohol” are only few ancient examples. More recently experimentation led the same species to concentrate on the qualities of some “blockbusters” like Tobacco, Cannabis, opium and cocaine.
openaire +1 more source